Shifts in gut microbiota composition in an APP/PSS1 transgenic mouse model of Alzheimer's disease during lifespan
- PMID:29575030
- DOI: 10.1111/lam.12882
Shifts in gut microbiota composition in an APP/PSS1 transgenic mouse model of Alzheimer's disease during lifespan
Abstract
Alzheimer's disease (AD) is the most common form of dementia and one of the major causes of disability and dependency in older people. Accumulating evidences link gut microbiota with different diseases and its relationship with neurodegenerative diseases is becoming most intriguing. This study was aimed to compare the gut microbiota of transgenic APP/PS1 (TG) mice, a well-established deterministic mouse model of AD, with their C57BL/6 wild-type (WT) littermates. Faecal samples were collected from 3-, 6- and 24-month-old mice and analysed by pyrosequencing of the V1-V3 region of the bacterial 16S rRNA genes. Bacterial profiles were similar in all young mice (3 months old), and started to diverge so that 6-month-old WT and TG mice had different and more diverse microbiota. During ageing, Turicibacteriaceae (typical mice bacterial group) and Rikenellaceae increased in all groups, although total Bacteroidetes remained stable. TG mice were characterized by an increase in Proteobacteria after 6 months, particularly the genus Sutterella (Betaproteobacteria), interestingly also increased in autism disorder. Also, the inflammation related family Erysipelotrichaceae was more abundant in TG mice at 24 months compared to wild-type control. In summary, AD pathology in mice shifts the gut microbiota towards profiles that share features with autism and inflammatory disorders.
Significance and impact of the study: Alzheimer's disease is a neurodegenerative disease and neuroinflammation in the central nervous system appears to have a pivotal role. Using the transgenic APP/PS1 (TG) mouse model, we successfully characterized how AD pathology shifted gut microbiota composition during ageing towards an inflammation related bacterial profile related to Proteobacteria and Erysipelotrichaceae and suggest that these changes could contribute to disease progression and severity. Microbiota-targeted interventions could therefore represent a strategy to postpone disease symptoms.
Keywords: disease processes; indicators; intestinal microbiology; markers; microbial structure.
© 2018 The Society for Applied Microbiology.
Similar articles
- Alzheimer's Disease Histological and Behavioral Manifestations in Transgenic Mice Correlate with Specific Gut Microbiome State.Shen L, Liu L, Ji HF.Shen L, et al.J Alzheimers Dis. 2017;56(1):385-390. doi: 10.3233/JAD-160884.J Alzheimers Dis. 2017.PMID:27911317
- Comparative analysis of gut bacterial communities of green turtles (Chelonia mydas) pre-hospitalization and post-rehabilitation by high-throughput sequencing of bacterial 16S rRNA gene.Ahasan MS, Waltzek TB, Huerlimann R, Ariel E.Ahasan MS, et al.Microbiol Res. 2018 Mar;207:91-99. doi: 10.1016/j.micres.2017.11.010. Epub 2017 Nov 21.Microbiol Res. 2018.PMID:29458874
- Characterization and comparison of the bacterial microbiota in different gastrointestinal tract compartments of Mongolian horses.Su S, Zhao Y, Liu Z, Liu G, Du M, Wu J, Bai D, Li B, Bou G, Zhang X, Dugarjaviin M.Su S, et al.Microbiologyopen. 2020 Jun;9(6):1085-1101. doi: 10.1002/mbo3.1020. Epub 2020 Mar 9.Microbiologyopen. 2020.PMID:32153142Free PMC article.
- Role of gut-brain axis, gut microbial composition, and probiotic intervention in Alzheimer's disease.Kesika P, Suganthy N, Sivamaruthi BS, Chaiyasut C.Kesika P, et al.Life Sci. 2021 Jan 1;264:118627. doi: 10.1016/j.lfs.2020.118627. Epub 2020 Oct 22.Life Sci. 2021.PMID:33169684Review.
- Gut Microbiota Composition and Epigenetic Molecular Changes Connected to the Pathogenesis of Alzheimer's Disease.Nagu P, Parashar A, Behl T, Mehta V.Nagu P, et al.J Mol Neurosci. 2021 Jul;71(7):1436-1455. doi: 10.1007/s12031-021-01829-3. Epub 2021 Apr 8.J Mol Neurosci. 2021.PMID:33829390Review.
Cited by
- Characterization of gut microbiota dynamics in an Alzheimer's disease mouse model through clade-specific marker-based analysis of shotgun metagenomic data.Favero F, Re A, Dason MS, Gravina T, Gagliardi M, Mellai M, Corazzari M, Corà D.Favero F, et al.Biol Direct. 2024 Oct 30;19(1):100. doi: 10.1186/s13062-024-00541-7.Biol Direct. 2024.PMID:39478626Free PMC article.
- Disrupted gut microbiota aggravates working memory dysfunction induced by high-altitude exposure in mice.Zhao Z, Cui D, Wu G, Ren H, Zhu X, Xie W, Zhang Y, Yang L, Peng W, Lai C, Huang Y, Li H.Zhao Z, et al.Front Microbiol. 2022 Nov 10;13:1054504. doi: 10.3389/fmicb.2022.1054504. eCollection 2022.Front Microbiol. 2022.PMID:36439863Free PMC article.
- Effects of Donepezil Treatment on Brain Metabolites, Gut Microbiota, and Gut Metabolites in an Amyloid Beta-Induced Cognitive Impairment Mouse Pilot Model.Jo JK, Lee G, Nguyen CD, Park SE, Kim EJ, Kim HW, Seo SH, Cho KM, Kwon SJ, Kim JH, Son HS.Jo JK, et al.Molecules. 2022 Oct 5;27(19):6591. doi: 10.3390/molecules27196591.Molecules. 2022.PMID:36235127Free PMC article.
- Recent advances in pre-clinical diagnosis of Alzheimer's disease.Zhou J, Benoit M, Sharoar MG.Zhou J, et al.Metab Brain Dis. 2022 Aug;37(6):1703-1725. doi: 10.1007/s11011-021-00733-4. Epub 2021 Apr 26.Metab Brain Dis. 2022.PMID:33900524Review.
- The sex-specific interaction of the microbiome in neurodegenerative diseases.Cox LM, Abou-El-Hassan H, Maghzi AH, Vincentini J, Weiner HL.Cox LM, et al.Brain Res. 2019 Dec 1;1724:146385. doi: 10.1016/j.brainres.2019.146385. Epub 2019 Aug 13.Brain Res. 2019.PMID:31419428Free PMC article.Review.
Publication types
MeSH terms
Substances
Related information
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous